CoChat

Revolutionizing Cancer Research: The Impact of Artificial Intelligence in Digital Biobanking

Open access
Frascarelli, Chiara, Bonizzi, Giuseppina, Musico, Camilla Rosella, Mane, Eltjona, Cassi, Cristina, Guerini Rocco, Elena, Farina, Annarosa, Scarpa, Aldo, Lawlor, Rita, Reggiani Bonetti, Luca, Caramaschi, Stefania, Eccher, Albino, Marletta, Stefano, Fusco, Nicola · 2023 · Journal of Personalized Medicine
Cited by 42

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Background. Biobanks are vital research infrastructures aiming to collect, process, store, and distribute biological specimens along with associated data in an organized and governed manner. Exploiting diverse datasets produced by the biobanks and the downstream research from various sources and integrating bioinformatics and “omics” data has proven instrumental in advancing research such as cancer research. Biobanks offer different types of biological samples matched with rich datasets comprising clinicopathologic information. As digital pathology and artificial intelligence (AI) have entered the precision medicine arena, biobanks are progressively transitioning from mere biorepositories to integrated computational databanks. Consequently, the application of AI and machine learning on these biobank datasets holds huge potential to profoundly impact cancer research. Methods. In this paper, we explore how AI and machine learning can respond to the digital evolution of biobanks with flexibility, solutions, and effective services. We look at the different data that ranges from specimen-related data, including digital images, patient health records and downstream genetic/genomic data and resulting “Big Data” and the analytic approaches used for analysis. Results. These cutting-edge technologies can address the challenges faced by translational and clinical research, enhancing their capabilities in data management, analysis, and interpretation. By leveraging AI, biobanks can unlock valuable insights from their vast repositories, enabling the identification of novel biomarkers, prediction of treatment responses, and ultimately facilitating the development of personalized cancer therapies. Conclusions. The integration of biobanking with AI has the potential not only to expand the current understanding of cancer biology but also to pave the way for more precise, patient-centric healthcare strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jpm13091390

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 42

Metadata

Authors
Frascarelli, C., Bonizzi, G., Musico, C. R., Mane, E., Cassi, C., Guerini Rocco, E., Farina, A., Scarpa, A., Lawlor, R., Reggiani Bonetti, L., Caramaschi, S., Eccher, A., Marletta, S., & Fusco, N.
Venue
Journal of Personalized Medicine
Publisher
MDPI AG
Published
2023-09-16
Volume
13
Issue
9
Pages
1390
ISSN
2075-4426 (ISSN-L)
OpenAlex
W4386814574
Cited by
42
References
8
FWCI
1.45
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Revolutionizing Cancer Research: The Impact of Artificial Intelligence in Digital Biobanking. https://app.cochat.ai/papers/10.3390/jpm13091390
The paper
Frascarelli, C., Bonizzi, G., Musico, C. R., Mane, E., Cassi, C., Guerini Rocco, E., Farina, A., Scarpa, A., Lawlor, R., Reggiani Bonetti, L., Caramaschi, S., Eccher, A., Marletta, S., & Fusco, N. (2023). Revolutionizing Cancer Research: The Impact of Artificial Intelligence in Digital Biobanking. Journal of Personalized Medicine. https://doi.org/10.3390/jpm13091390

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.